'
Kopran hosted a
conference call on Feb 15, 2025, which was hosted by the following
representatives: Mr. Surendra Somani, Executive Vice Chairman, and Mr. Sanjay
Dosi, Advisor.
Key takeaways of the call
The environment
in the API industry remains challenging. However, management expects gradual
recovery in the API business.
In Q3 FY25, net
profits were impacted by forex losses due to mark-to-market accounting. During
the quarter, the company reported forex losses of Rs 3.07 crore.
The company is
engaged in various CMO projects for 15 dosage forms and CDMO projects for 11
dosage forms, which are either completed or near completion and focused for the
regulated markets.
Further, CMO
projects for 8 dosage forms and CDMO projects for 10 dosage forms are under
development again for the regulated markets. Commercialization is expected between
12 to 24 month...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|